Bottom line
SHSAX vs SCHLX: the short answer
SHSAX (Blackrock Health Sciences Opportunities Portfolio) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But SHSAX is far broader, holding 155 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.11% — a difference of $5.00 a year per $10,000 invested.
SHSAX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
SHSAX vs SCHLX side by side
| SHSAX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 1.06% |
| Annual cost per $10k | $111 | $106 |
| 10-yr cost on $10k (prospectus) | $1,806 | $1,294 |
| Max front load | 5.25% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.9% | — |
| 5-yr return (annualized) | +4.5% | — |
| 10-yr return (annualized) | +9.0% | — |
| Best quarter | +17.5% | — |
| Worst quarter | −11.5% | — |
| Net assets (fund) | $5.9B | $231.8M |
| Number of holdings | 155 | 65 |
| Portfolio turnover | 49% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of SHSAX's top 25 holdings also appear in SCHLX's top 25.
| Holding | SHSAX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 13.85% |
| Johnson & Johnson | 8.77% | 6.19% |
| Unitedhealth Group Inc | 6.10% | 5.73% |
| Merck & Company Inc | 4.94% | 4.85% |
| Gilead Sciences Inc | 4.19% | 2.78% |
| Abbvie Inc | 3.94% | 4.90% |
| Amgen Inc | 3.37% | 2.88% |
| Thermo Fisher Scientific Inc | 3.02% | 3.46% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.45% |
| Pfizer Inc | 2.61% | 1.17% |
| Danaher Corp | 2.00% | 2.13% |
| Abbott Laboratories | 1.97% | 2.39% |
| Intuitive Surgical Inc | 1.95% | 2.69% |
| Boston Scientific Corp | 1.59% | 2.10% |
| Astrazeneca Plc | 1.21% | 3.80% |
Source: SEC Form N-PORT
SHSAX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between SHSAX and SCHLX?
Which is cheaper, SHSAX or SCHLX?
Should I own both SHSAX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.